Epsilico
Generating drugs for the toughest targets
Berlin, Germany
7 employees
Seed
Biotechnology, Life Sciences +1
General Information
Berlin, Germany
BounceWatch is an independent company data service, not affiliated with Epsilico. To contact Epsilico, visit epsilico.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Epsilico compare?
A PDF of Epsilico and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Epsilico soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Germany Market
Biotechnology
About Epsilico
Business keywords: drug discovery, pharmaceutical research, therapeutic design, proprietary technology, advanced lab processes
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | Undisclosed | 2 |
|
16 May 2022 |
| Pre Seed Round | Undisclosed | 1 |
|
30 Dec 2020 |
Epsilico Alternatives & Competitors
View All Alternatives
The right environment for drug discovery
Designing functional antibodies for the most challenging targets.
Unlocking the potential of peptides macrocycles to create tomorrow's life-changing medicines with Ge...
FAQ About Epsilico
Source: BounceWatch company record for Epsilico, https://bouncewatch.com/company/cinference, updated 29 December 2024. When citing, please name BounceWatch and link this page.
